Literature DB >> 27399808

The clinicopathologic significance of estrogen receptors in human gastric carcinoma.

M Wesołowska1, P Pawlik2, P P Jagodziński2.   

Abstract

In most populations, gastric cancer (GC) is approximately two times more prevalent in men than in women, which may suggest the protective role of sex steroid hormones in gastric carcinogenesis. Steroid hormones such as androgens and estrogens can be synthesized not only in the gonads but also in peripheral tissues. Many researchers have conducted studies examining the expression profile of enzymes involved in steroid synthesis, the occurrence of estrogen receptors (ERs) and the influence of ERs in the development, proliferation and progression of gastric cancer. Some studies have also evaluated the relationship between the presence of ERs and survival prognosis. However, the results of these studies are often controversial and divergent. In a recent study, it was indicated that sex steroid hormones and estrogen receptors are partly involved in gastric cancer but their clinicopathological significance still needs further investigation.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Estrogen receptors; GPR30; Gastric cancer

Mesh:

Substances:

Year:  2016        PMID: 27399808     DOI: 10.1016/j.biopha.2016.06.048

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  Gastrointestinal Tract Metastases of Invasive Lobular Carcinoma of the Breast: An Immunohistochemical Survey Algorithm.

Authors:  Baha Zengel; Demet Çavdar; Özlem Özdemir; Funda Taşlı; Murat Karataş; Cenk Şimşek; Adam Uslu
Journal:  Eur J Breast Health       Date:  2022-10-01

2.  Inhibitors Targeting Multiple Janus Kinases From Zanthoxylum simulans Mediate Inhibition and Apoptosis Against Gastric Cancer Cells via the Estrogen Pathway.

Authors:  Yong-Qiang Tian; Dai Hu; Yong-Li Zhang; Jian Zou; Gui-Lin Chen; Ming-Quan Guo
Journal:  Front Chem       Date:  2022-06-06       Impact factor: 5.545

Review 3.  The roles of estrogen and estrogen receptors in gastrointestinal disease.

Authors:  Changmei Chen; Xiang Gong; Xiaoxu Yang; Xianhui Shang; Qian Du; Qiushi Liao; Rui Xie; Yuanshou Chen; Jingyu Xu
Journal:  Oncol Lett       Date:  2019-10-11       Impact factor: 2.967

4.  Clinicopathological features and prognoses in younger and older patients with gastric cancer.

Authors:  Shubin Song; Chunfeng Li; Sen Li; Xiliang Cong; Yingwei Xue
Journal:  Onco Targets Ther       Date:  2017-09-27       Impact factor: 4.147

5.  Homeobox B7 accelerates the cancer progression of gastric carcinoma cells by promoting epithelial-mesenchymal transition (EMT) and activating Src-FAK pathway.

Authors:  Jianghong Wu; Ziwen Long; Hong Cai; Shengjia Yu; Xiaowen Liu
Journal:  Onco Targets Ther       Date:  2019-05-16       Impact factor: 4.147

6.  Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transition.

Authors:  Xiaofeng Wang; Zhiyuan Xu; Jiancheng Sun; Hang Lv; Yiping Wang; Yixiu Ni; Shangqi Chen; Can Hu; Lijing Wang; Wei Chen; Xiangdong Cheng
Journal:  J Cell Mol Med       Date:  2020-02-12       Impact factor: 5.310

7.  GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT-Mediated EMT.

Authors:  En Xu; Xuefeng Xia; Chaoyu Jiang; Zijian Li; Zhi Yang; Chang Zheng; Xingzhou Wang; Shangce Du; Ji Miao; Feng Wang; Yizhou Wang; Xiaofeng Lu; Wenxian Guan
Journal:  Front Cell Dev Biol       Date:  2020-12-21

Review 8.  Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs.

Authors:  Zhen Zeng; Chunxiang Ma; Kexin Chen; Mingshan Jiang; Reshma Vasu; Rui Liu; Yinglan Zhao; Hu Zhang
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

Review 9.  Gastric Cancer in Young Adults: A Different Clinical Entity from Carcinogenesis to Prognosis.

Authors:  Jian Li
Journal:  Gastroenterol Res Pract       Date:  2020-03-02       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.